Technical Analysis for AKBA - Akebia Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Centerline Cross | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
New 52 Week Closing High | Bullish | 0.00% | |
Expansion Breakout | Bullish Swing Setup | 0.00% | |
Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
New 52 Week High | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% |
Alert | Time |
---|---|
Up 2 ATRs | about 8 hours ago |
Possible Pocket Pivot | about 9 hours ago |
New 52 Week High | about 10 hours ago |
Up 10% | about 10 hours ago |
Up 1 ATR | about 10 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/07/2024
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Kidney Disease Dialysis Anemia Chronic Kidney Disease Kidney Hypoxia Inducible Factors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Kidney Disease Dialysis Anemia Chronic Kidney Disease Kidney Hypoxia Inducible Factors
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.05 |
52 Week Low | 0.4901 |
Average Volume | 2,642,689 |
200-Day Moving Average | 1.25 |
50-Day Moving Average | 1.54 |
20-Day Moving Average | 1.52 |
10-Day Moving Average | 1.52 |
Average True Range | 0.15 |
RSI (14) | 67.53 |
ADX | 21.07 |
+DI | 40.25 |
-DI | 14.30 |
Chandelier Exit (Long, 3 ATRs) | 1.59 |
Chandelier Exit (Short, 3 ATRs) | 1.78 |
Upper Bollinger Bands | 1.79 |
Lower Bollinger Band | 1.25 |
Percent B (%b) | 1.18 |
BandWidth | 35.31 |
MACD Line | 0.03 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0244 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.42 | ||||
Resistance 3 (R3) | 2.42 | 2.23 | 2.33 | ||
Resistance 2 (R2) | 2.23 | 2.10 | 2.24 | 2.30 | |
Resistance 1 (R1) | 2.06 | 2.01 | 2.15 | 2.07 | 2.27 |
Pivot Point | 1.88 | 1.88 | 1.92 | 1.88 | 1.88 |
Support 1 (S1) | 1.71 | 1.74 | 1.79 | 1.71 | 1.51 |
Support 2 (S2) | 1.52 | 1.66 | 1.53 | 1.48 | |
Support 3 (S3) | 1.35 | 1.52 | 1.45 | ||
Support 4 (S4) | 1.36 |